Table 3. Enriched KEGG pathways involving target genes of eight high-abundance miRNAs (P<0.05).
| Pathway ID | Definition | Hits | Total | Percent (%) | Fisher-P value |
|---|---|---|---|---|---|
| cfa04145 | Phagosome | 11 | 141 | 7.80% | 3.07E-03 |
| cfa04520 | Adherens junction | 7 | 73 | 9.59% | 5.73E-03 |
| cfa04919 | Thyroid hormone signaling pathway | 9 | 115 | 7.83% | 7.04E-03 |
| cfa04142 | Lysosome | 9 | 117 | 7.69% | 7.86E-03 |
| cfa04320 | Dorsoventral axis formation | 4 | 28 | 14.29% | 8.87E-03 |
| cfa05412 | Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 6 | 72 | 8.33% | 1.97E-02 |
| cfa05152 | Tuberculosis | 10 | 164 | 6.10% | 2.40E-02 |
| cfa04916 | Melanogenesis | 7 | 100 | 7.00% | 2.89E-02 |
| cfa05323 | Rheumatoid arthritis | 6 | 82 | 7.32% | 3.47E-02 |
| cfa04390 | Hippo signaling pathway | 9 | 153 | 5.88% | 3.83E-02 |
| cfa05414 | Dilated cardiomyopathy | 6 | 85 | 7.06% | 4.03E-02 |
| cfa00130 | Ubiquinone and other terpenoid-quinone biosynthesis | 2 | 11 | 18.18% | 4.05E-02 |
| cfa03420 | Nucleotide excision repair | 4 | 44 | 9.09% | 4.08E-02 |